Subtopic Deep Dive
Vitamin D and Cardiovascular Disease
Research Guide
What is Vitamin D and Cardiovascular Disease?
Vitamin D and Cardiovascular Disease examines the association between vitamin D deficiency and increased risks of hypertension, myocardial infarction, heart failure, and other cardiovascular events through cohort studies, Mendelian randomization, and supplementation trials.
Prospective cohort studies link low 25-hydroxyvitamin D levels to higher CVD incidence (Wang et al., 2008, 2369 citations). Vitamin D receptors in vascular smooth muscle and cardiomyocytes suggest mechanistic roles (Bouillon et al., 2008, 1758 citations). 1,25-Dihydroxyvitamin D3 suppresses renin-angiotensin system activation, a key hypertension driver (Li et al., 2002, 1607 citations).
Why It Matters
Wang et al. (2008) demonstrated in the Framingham Heart Study that vitamin D deficiency predicts CVD events independent of traditional risk factors, potentially guiding screening in millions with low levels. Li et al. (2002) showed 1,25-(OH)2D3 directly inhibits renin expression in mice, offering a pathway for hypertension prevention via supplementation. Poljšak et al. (2013) connected vitamin D's antioxidant effects to reduced oxidative stress in CVD. Clarifying causality could reduce global CVD mortality, the top killer, by informing public health supplementation policies.
Key Research Challenges
Establishing Causality
Observational data show associations, but RCTs often fail to confirm benefits (Wang et al., 2008; Trivedi et al., 2003). Mendelian randomization studies are needed to address confounding. Reverse causation from illness lowering vitamin D complicates interpretations.
Optimal Supplementation Dosing
Trials like Trivedi et al. (2003) used 100,000 IU every four months with mixed CVD outcomes. Dose-response relationships remain unclear for hypertension prevention (Li et al., 2002). Individual variability in receptor expression affects efficacy (Bouillon et al., 2008).
Mechanistic Heterogeneity
Vitamin D impacts renin-angiotensin, ROS, and endothelial function differently across tissues (Li et al., 2002; Poljšak et al., 2013). Null mouse models reveal broad effects but human translation is limited (Bouillon et al., 2008). Biomarker standardization hinders comparisons.
Essential Papers
Vitamin D Deficiency and Risk of Cardiovascular Disease
Thomas J. Wang, Michael J. Pencina, Sarah L. Booth et al. · 2008 · Circulation · 2.4K citations
Background— Vitamin D receptors have a broad tissue distribution that includes vascular smooth muscle, endothelium, and cardiomyocytes. A growing body of evidence suggests that vitamin D deficiency...
Evidence that Vitamin D Supplementation Could Reduce Risk of Influenza and COVID-19 Infections and Deaths
William B. Grant, Henry Lahore, Sharon L. McDonnell et al. · 2020 · Nutrients · 2.0K citations
The world is in the grip of the COVID-19 pandemic. Public health measures that can reduce the risk of infection and death in addition to quarantines are desperately needed. This article reviews the...
Vitamin D and Human Health: Lessons from Vitamin D Receptor Null Mice
Roger Bouillon, Geert Carmeliet, Lieve Verlinden et al. · 2008 · Endocrine Reviews · 1.8K citations
Abstract The vitamin D endocrine system is essential for calcium and bone homeostasis. The precise mode of action and the full spectrum of activities of the vitamin D hormone, 1,25-dihydroxyvitamin...
1,25-Dihydroxyvitamin D3 is a negative endocrine regulator of the renin-angiotensin system
Yan Chun Li, Juan Kong, Minjie Wei et al. · 2002 · Journal of Clinical Investigation · 1.6K citations
Inappropriate activation of the renin-angiotensin system, which plays a central role in the regulation of blood pressure, electrolyte, and volume homeostasis, may represent a major risk factor for ...
Achieving the Balance between ROS and Antioxidants: When to Use the Synthetic Antioxidants
Borut Poljšak, Dušan Šuput, Irina Milisav · 2013 · Oxidative Medicine and Cellular Longevity · 1.3K citations
Free radical damage is linked to formation of many degenerative diseases, including cancer, cardiovascular disease, cataracts, and aging. Excessive reactive oxygen species (ROS) formation can induc...
Effect of four monthly oral vitamin D <sub>3</sub> (cholecalciferol) supplementation on fractures and mortality in men and women living in the community: randomised double blind controlled trial
Daksha Trivedi, Richard Doll, Kay Tee Khaw · 2003 · BMJ · 1.3K citations
Abstract Objective: To determine the effect of four monthly vitamin D supplementation on the rate of fractures in men and women aged 65 years and over living in the community. Design: Randomised do...
Vitamin D for Health: A Global Perspective
Arash Hossein‐Nezhad, Michael F. Holick · 2013 · Mayo Clinic Proceedings · 1.3K citations
Reading Guide
Foundational Papers
Start with Wang et al. (2008) for epidemiological evidence from Framingham cohort linking deficiency to CVD events; Li et al. (2002) for mechanistic renin suppression; Bouillon et al. (2008) for VDR tissue roles.
Recent Advances
Bolland et al. (2010) meta-analysis on calcium-vitamin D MI risks; Poljšak et al. (2013) on antioxidants in CVD; review Grant et al. (2020) for broader deficiency impacts.
Core Methods
Cohort analysis of 25(OH)D quartiles vs HRs (Wang 2008); VDR-null mouse phenotypes (Bouillon 2008); renin mRNA suppression assays (Li 2002); RCT fracture/mortality endpoints adaptable to CVD (Trivedi 2003).
How PapersFlow Helps You Research Vitamin D and Cardiovascular Disease
Discover & Search
Research Agent uses searchPapers('vitamin D deficiency cardiovascular disease cohort') to find Wang et al. (2008, Circulation, 2369 citations), then citationGraph reveals forward citations like Bolland et al. (2010) on calcium risks, and findSimilarPapers identifies Li et al. (2002) for renin mechanisms.
Analyze & Verify
Analysis Agent applies readPaperContent on Wang et al. (2008) to extract HRs for CVD events, verifyResponse with CoVe checks claims against Bouillon et al. (2008), and runPythonAnalysis re-analyzes Framingham cohort hazard ratios using pandas for dose-response curves with GRADE grading for evidence strength.
Synthesize & Write
Synthesis Agent detects gaps in RCT causality post-Wang et al. (2008), flags contradictions between observational and trial data; Writing Agent uses latexEditText for meta-analysis tables, latexSyncCitations for 10+ papers, latexCompile for figures, and exportMermaid for renin pathway diagrams.
Use Cases
"Extract and plot hazard ratios for vitamin D levels vs CVD events from Wang 2008 Framingham data"
Research Agent → searchPapers → Analysis Agent → readPaperContent + runPythonAnalysis (pandas/matplotlib plots HR curves) → researcher gets CSV-exported dose-response graph with statistical p-values.
"Draft LaTeX review section on vitamin D renin suppression with citations"
Synthesis Agent → gap detection → Writing Agent → latexEditText + latexSyncCitations (Wang 2008, Li 2002) + latexCompile → researcher gets compiled PDF section with synced bibliography.
"Find GitHub repos analyzing vitamin D CVD Mendelian randomization"
Research Agent → citationGraph on Li 2002 → Code Discovery (paperExtractUrls → paperFindGithubRepo → githubRepoInspect) → researcher gets inspected R scripts for MR analysis with execution previews.
Automated Workflows
Deep Research workflow runs systematic review: searchPapers(50+ vitamin D CVD papers) → DeepScan(7-step analysis with GRADE checkpoints on Wang 2008 causality) → structured report with meta-HRs. Theorizer generates hypotheses on supplementation failure from Li 2002 mechanisms + Bolland 2010 interactions. Chain-of-Verification/CoVe verifies all claims against Trivedi 2003 trial data.
Frequently Asked Questions
What defines this subtopic?
Vitamin D and Cardiovascular Disease studies links between low 25(OH)D levels and risks of hypertension, MI, and heart failure using cohorts, MR, and trials (Wang et al., 2008).
What are key methods used?
Prospective cohorts measure 25(OH)D vs CVD events (Wang et al., 2008); mouse models test VDR-null effects (Bouillon et al., 2008); RCTs test supplementation (Trivedi et al., 2003).
What are seminal papers?
Wang et al. (2008, 2369 citations) links deficiency to CVD in Framingham; Li et al. (2002, 1607 citations) shows renin suppression; Bouillon et al. (2008, 1758 citations) details VDR roles.
What open problems remain?
RCTs show inconsistent supplementation benefits despite associations (Trivedi et al., 2003; Bolland et al., 2010); causality needs MR validation; optimal dosing for CVD prevention unclear.
Research Vitamin D Research Studies with AI
PapersFlow provides specialized AI tools for Medicine researchers. Here are the most relevant for this topic:
Systematic Review
AI-powered evidence synthesis with documented search strategies
AI Literature Review
Automate paper discovery and synthesis across 474M+ papers
Find Disagreement
Discover conflicting findings and counter-evidence
Paper Summarizer
Get structured summaries of any paper in seconds
See how researchers in Health & Medicine use PapersFlow
Field-specific workflows, example queries, and use cases.
Start Researching Vitamin D and Cardiovascular Disease with AI
Search 474M+ papers, run AI-powered literature reviews, and write with integrated citations — all in one workspace.
See how PapersFlow works for Medicine researchers
Part of the Vitamin D Research Studies Research Guide